Rhumbline Advisers Surmodics Inc Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Surmodics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 19,955 shares of SRDX stock, worth $830,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,955
Previous 20,628
3.26%
Holding current value
$830,327
Previous $612,000
2.61%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding SRDX
# of Institutions
157Shares Held
11.8MCall Options Held
219KPut Options Held
255K-
Black Rock Inc. New York, NY1.17MShares$48.7 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY887KShares$36.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$33.7 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I0610KShares$25.4 Million0.69% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT536KShares$22.3 Million0.06% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $583M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...